You are here: Home

ICBP SURVMARK-2 (Cancer Survival in High-Income Countries) will produce high impact cancer survival, incidence and mortality comparisons as part of the International Cancer Benchmarking Partnership (ICBP). The ICBP is a unique and innovative collaboration that brings together clinicians, policy-makers, researchers, and cancer data experts. It aims to measure international differences in cancer survival, and crucially, to identify factors that might be driving these differences.

The ICBP SURVMARK-2 project was launched in July 2016 and is set to be completed in early 2020.


The 3rd call for ICBP SurvMark-2 Expertise Transfer fellowship is now closed. The next call will be opened on 3 May 2019 with a deadline on 3 July 2019 at 5.00 pm GMT - April 2019

Deadline for the 3rd call for ICBP SurvMark-2 Expertise Transfer fellowship is Monday 1 April 2019 (5.00 pm GMT) - March 2019

The 3rd ICBP SurvMark-2 Executive group meeting was held at IARC, Lyon (France) on 25 and 26 February 2019 - March 2019

At the 2018 World Cancer Congress held in Kuala Lumpur (Malaysia), Dr Freddie Bray presented the ICBP SurvMark-2 project during Track 3 "Improved and sustainable healthcare systems for better outcomes / Improving cancer outcomes through international partnerships". His presentation "ICBP SURVMARK-2: a comprehensive and innovative approach to international cancer survival benchmarking" is available here - November 2018

The successful applicants to the second call for expertise transfer fellowships are Tanya Navaneelan, Research Associate – Epidemiology, Cancer Care Ontario (Canada) and Guillaume Ruel, Analyst, Department of Cancerology, Ministry of Health and Social service, Québec (Canada). They will be hosted at IARC mid-2019 - March 2019

The 40th Annual Scientific meeting of the International Association for Cancer Registries was held in Arequipa (Peru) on 12-15 November 2018. More info here - November 2018

The successful applicants to the first call for expertise transfer fellowships are Dr Eileen Morgan and Mr Hazem Ab Elkader. Dr Morgan will be hosted at IARC in Oct-Dec. 2018 to investigate trends in survival of oesophageal cancer by histological sites and countries. Mr Abd Elkader will then be hosted in April-May 2019 to study the avoidable death for the eight ICBP cancer sites (colon, rectum, lung, ovary, oesophagus, stomach, pancreas and liver) as well as melanoma of the skin - September 2018

An overview of the ICBP SURVMARK2 project and upcoming activities were presented on 12 June 2018 during the annual NAACCR conference in Pittsburgh (USA) and on 20 June 2018 during the PHE Cancer Services, Data & Outcomes Conferences in Manchester (UK) - July 2018

As part of the Summer School on Modern Methods in Biostatistics and Epidemiology, Paul Dickman and Paul Lambert presented an intensive 1-week course on the principles, methods and application of statistical methods in population-based cancer survival analysis. Further details are available here - July 2018

An ICBP Phase 2 researcher workshop was held on 20 February 2018 in London with attendees from the Programme Board, SurvMark-2 team, Cancer Patient Pathways, Health systems, Clinicians and Programme team - March 2018

A SURVMARK-2 Meeting was organized during the 39th Annual Conference of the International Association of Cancer Registries on 18 October 2017 with SURVMARK-2 colleagues and partners present during the conference.

Kick-off meeting of the executive group held in London on 27/28 March 2017. View photo

SURVMARK-2 call for data launched in July 2016 – 20 jurisdictions from 6 countries participating.